Novo boosts sales outlook on strong demand for obesity drug
Bio Pharma Dive
APRIL 13, 2023
The Danish drugmaker nearly doubled the 2023 forecasts for Wegovy and Ozempic in the latest indicator of the sales potential of an emerging and competitive class of weight loss drugs.
Let's personalize your content